Challenging Alzheimer's: Korean Firms Forge Ahead In Multiple Modalities
Hopes RIse As Diverse Contenders Enter Late-Stage Trials
In Vivo takes an infographic look at where South Korea stands in the development of a wide-ranging set of drugs for Alzheimer’s disease and which companies are still in the challenging race.
